Literature DB >> 17375221

Inhibition of rats extramedullary liver erytropoiesis by hyperbaric oxygen therapy.

Ricardo Costa-Val1, Tarcizo Afonso Nunes, Roberto Carlos de Oliveira E Silva, Antônio Francisco de Souza, Irene Edith de Puy E Souza, Tatiana Karina de Puy E Souza.   

Abstract

PURPOSE: To research the hyperbaric oxygen therapy effects on rats' livers and spleens.
METHODS: 30 adult male Hotzman rats were used, being randomly distributed, by raffle, into 2 groups of 15 animals each: group 1 - control; group 2 - hyperbaric oxygen therapy. Group-2 animals underwent hyperbaric oxygen therapy for 120 minutes daily, 90 minutes of which were under pressure of 2.5 atmospheres. The first and last 15 minutes were used for gradual compression and decompression, respectively, for 20 days in a row. The livers and spleens of the animals from the two groups were taken out for histologic examination, on the day after the end of hyperbaric oxygen therapy in group 2 animals. Liver and spleen histologic changes of the animals from the two groups were compared by using Fisher exact test. P < 0.05 was regarded as a significant difference.
RESULTS: The only change in liver and spleen histology was the significant reduction in hepatic extramedullary erythropoiesis in the animals that underwent hyperbaric oxygen therapy (p < 0.05).
CONCLUSION: Hyperbaric oxygen therapy reduces hepatic extramedullary erythropoiesis in rats and doesn't jeopardize the other liver and spleen structures.

Entities:  

Mesh:

Year:  2007        PMID: 17375221     DOI: 10.1590/s0102-86502007000200011

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  I. Embryonal vasculature formation recapitulated in transgenic mammary tumor spheroids implanted pseudo-orthotopicly into mouse dorsal skin fold: the organoblasts concept.

Authors:  Halina Witkiewicz; Phil Oh; Jan E Schnitzer
Journal:  F1000Res       Date:  2013-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.